Mortality prediction in Chagas heart disease

References

• Biolo A, Ribeiro AL, Clausell N. Chagas cardiomyopathy – where do we stand after a hundred years? Prog. Cardiovasc. Dis. 52(4), 300–316 (2010).
   PubMed Web of Science ®Google Scholar
• Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 115(1–2), 14–21 (2010).
   PubMed Web of Science ®Google Scholar
• Coura JR, Viñas PA. Chagas disease: a new worldwide challenge. Nature 465(7301), S6–S7 (2010).
   PubMed Web of Science ®Google Scholar
• Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas’ disease in the USA. Clin. Microbiol. Rev. 24(4), 655–681 (2011).
   PubMed Web of Science ®Google Scholar
• Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1(2), 92–100 (2001).
   PubMedGoogle Scholar
• Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 375(9723), 1388–1402 (2010).
   PubMed Web of Science ®Google Scholar
• Rocha MO, Teixeira MM, Ribeiro AL. An update on the management of Chagas cardiomyopathy. Expert Rev. Anti. Infect. Ther. 5(4), 727–743 (2007).
   PubMed Web of Science ®Google Scholar
• Coura JR. Chagas disease: what is known and what is needed – a background article. Mem. Inst. Oswaldo Cruz 102(Suppl. 1), 113–122 (2007).
   PubMed Web of Science ®Google Scholar
• Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation 115(9), 1109–1123 (2007).
   PubMed Web of Science ®Google Scholar
• Machado FS, Tyler KM, Brant F, Esper L, Teixeira MM, Tanowitz HB. Pathogenesis of Chagas disease: time to move on. Front. Biosci. (Elite Ed.) 4, 1743–1758 (2012).
   PubMedGoogle Scholar
• Talvani A, Teixeira MM. Inflammation and Chagas disease some mechanisms and relevance. Adv. Parasitol. 76, 171–194 (2011).
   PubMed Web of Science ®Google Scholar
• Maguire JH, Hoff R, Sherlock I et al. Cardiac morbidity and mortality due to Chagas’ disease: prospective electrocardiographic study of a Brazilian community. Circulation 75(6), 1140–1145 (1987).
   PubMed Web of Science ®Google Scholar
• Viotti RJ, Vigliano C, Laucella S et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 90(6), 655–660 (2004).
   PubMed Web of Science ®Google Scholar
• Acquatella H. Echocardiography in Chagas heart disease. Circulation 115(9), 1124–1131 (2007).
   PubMed Web of Science ®Google Scholar
• Coura JR, Borges-Pereira J. Chagas disease: 100 years after its discovery. A systemic review. Acta Trop. 115(1–2), 5–13 (2010).
   PubMed Web of Science ®Google Scholar
• Rocha MO, Ribeiro AL, Teixeira MM. Clinical management of chronic Chagas cardiomyopathy. Front. Biosci. 8, e44–e54 (2003).
   PubMed Web of Science ®Google Scholar
• Rassi A Jr, Rassi A, Little WC. Chagas’ heart disease. Clin. Cardiol. 23(12), 883–889 (2000).
   PubMed Web of Science ®Google Scholar
• Bestetti R. Stroke in a hospital-derived cohort of patients with chronic Chagas’ disease. Acta Cardiol. 55(1), 33–38 (2000).
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 36(5), 965–970 (2005).
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, Ribeiro Lda S, Vargas AP. Awareness of stroke risk in Chagasic stroke patients. J. Neurol. Sci. 263(1–2), 35–39 (2007).
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, Gascon J. Chagas disease and stroke. Lancet Neurol. 9(5), 533–542 (2010).
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ. Stroke: a neglected complication of American trypanosomiasis (Chagas’ disease). Trans. R. Soc. Trop. Med. Hyg. 101(11), 1075–1080 (2007).
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ. Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke. Expert Rev. Cardiovasc. Ther. 8(5), 717–728 (2010).
   PubMedGoogle Scholar
• Lima-Costa MF, Matos DL, Ribeiro AL. Chagas disease predicts 10-year stroke mortality in community-dwelling elderly: the Bambui cohort study of aging. Stroke 41(11), 2477–2482 (2010).
   PubMed Web of Science ®Google Scholar
• Paixão LC, Ribeiro AL, Valacio RA, Teixeira AL. Chagas disease: independent risk factor for stroke. Stroke 40(12), 3691–3694 (2009).
   PubMed Web of Science ®Google Scholar
• Nunes Mdo C, Barbosa MM, Rocha MO. Peculiar aspects of cardiogenic embolism in patients with Chagas’ cardiomyopathy: a transthoracic and transesophageal echocardiographic study. J. Am. Soc. Echocardiogr. 18(7), 761–767 (2005).
   PubMed Web of Science ®Google Scholar
• Nunes MC, Barbosa MM, Ribeiro AL, Barbosa FB, Rocha MO. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study. J. Neurol. Sci. 278(1–2), 96–101 (2009).
   PubMed Web of Science ®Google Scholar
• Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas’ disease. Arq. Bras. Cardiol. 76(1), 75–96 (2001).
   PubMedGoogle Scholar
• Ribeiro AL, Rocha MO. [Indeterminate form of Chagas disease: considerations about diagnosis and prognosis]. Rev. Soc. Bras. Med. Trop. 31(3), 301–314 (1998).
   PubMedGoogle Scholar
• Rocha MO, Nunes MC, Ribeiro AL. Morbidity and prognostic factors in chronic Chagasic cardiopathy. Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 159–166 (2009).
   PubMed Web of Science ®Google Scholar
• Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 115(9), 1101–1108 (2007).
   PubMed Web of Science ®Google Scholar
• Basquiera AL, Sembaj A, Aguerri AM et al. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 89(10), 1186–1190 (2003).
   PubMed Web of Science ®Google Scholar
• Marin-Neto JA, Almeida Filho OC, Pazin-Filho A, Maciel BC. [Indeterminate form of Chagas’ disease. Proposal of new diagnostic criteria and perspectives for early treatment of cardiomyopathy]. Arq. Bras. Cardiol. 79(6), 623–627 (2002).
   PubMedGoogle Scholar
• Ianni BM, Arteaga E, Frimm CC, Pereira Barretto AC, Mady C. Chagas’ heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq. Bras. Cardiol. 77(1), 59–62 (2001).
   PubMedGoogle Scholar
• Coura JR, de Abreu LL, Pereira JB, Willcox HP. [Morbidity in Chagas’ disease. IV. Longitudinal study of 10 years in Pains and Iguatama, Minas Gerais, Brazil]. Mem. Inst. Oswaldo Cruz 80(1), 73–80 (1985).
   PubMedGoogle Scholar
• Pazin-Filho A, Romano MM, Almeida-Filho OC et al. Minor segmental wall motion abnormalities detected in patients with Chagas’ disease have adverse prognostic implications. Braz. J. Med. Biol. Res. 39(4), 483–487 (2006).
   PubMed Web of Science ®Google Scholar
• Viotti R, Vigliano C, Lococo B et al. Exercise stress testing as a predictor of progression of early chronic Chagas heart disease. Heart 92(3), 403–404 (2006).
   PubMed Web of Science ®Google Scholar
• Dutra WO, Gollob KJ. Current concepts in immunoregulation and pathology of human Chagas disease. Curr. Opin. Infect. Dis. 21(3), 287–292 (2008).
   PubMed Web of Science ®Google Scholar
• Wallukat G, Muñoz Saravia SG, Haberland A et al. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas’ cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas’ patients. J. Am. Coll. Cardiol. 55(5), 463–468 (2010).
   PubMed Web of Science ®Google Scholar
• Campelo V, Dantas RO, Simões RT et al. TNF microsatellite alleles in Brazilian Chagasic patients. Dig. Dis. Sci. 52(12), 3334–3339 (2007).
   PubMed Web of Science ®Google Scholar
• Fernández-Mestre MT, Montagnani S, Layrisse Z. Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease? Hum. Immunol. 65(7), 725–728 (2004).
   PubMed Web of Science ®Google Scholar
• Calzada JE, Nieto A, Beraún Y, Martín J. Chemokine receptor CCR5 polymorphisms and Chagas’ disease cardiomyopathy. Tissue Antigens 58(3), 154–158 (2001).
   PubMedGoogle Scholar
• Barretto AC, Arteaga E, Mady C, Ianni BM, Bellotti G, Pileggi F. [Male sex. Prognostic factor in Chagas’ disease]. Arq. Bras. Cardiol. 60(4), 225–227 (1993).
   PubMedGoogle Scholar
• Espinosa R, Carrasco HA, Belandria F et al. Life expectancy analysis in patients with Chagas’ disease: prognosis after one decade (1973-1983). Int. J. Cardiol. 8(1), 45–56 (1985).
   PubMed Web of Science ®Google Scholar
• Rassi A Jr, Rassi A, Little WC et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N. Engl. J. Med. 355(8), 799–808 (2006).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Salas LA, Klein E, Acquatella H et al. Echocardiographic and clinical predictors of mortality in chronic Chagas’ disease. Echocardiography 15(3), 271–278 (1998).
   PubMed Web of Science ®Google Scholar
• Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardoso C. Prognostic value of QT interval parameters for mortality risk stratification in Chagas’ disease: results of a long-term follow-up study. Circulation 108(3), 305–312 (2003).
   PubMed Web of Science ®Google Scholar
• Leite LR, Fenelon G, Simoes A Jr, Silva GG, Friedman PA, de Paola AA. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic Chagasic cardiomyopathy treated with amiodarone or sotalol. J. Cardiovasc. Electrophysiol. 14(6), 567–573 (2003).
   PubMed Web of Science ®Google Scholar
• Carrasco HA, Parada H, Guerrero L, Duque M, Durán D, Molina C. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas’ disease. Int. J. Cardiol. 43(1), 27–38 (1994).
   PubMed Web of Science ®Google Scholar
• Moya A, Sutton R, Ammirati F et al.; Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS). Guidelines for the diagnosis and management of syncope (version 2009). Eur. Heart J. 30(21), 2631–2671 (2009).
   PubMed Web of Science ®Google Scholar
• Martinelli Filho M, Sosa E, Nishioka S, Scanavacca M, Bellotti G, Pileggi F. Clinical and electrophysiologic features of syncope in chronic Chagasic heart disease. J. Cardiovasc. Electrophysiol. 5(7), 563–570 (1994).
   PubMed Web of Science ®Google Scholar
• Bestetti RB, Otaviano AP, Cardinalli-Neto A, da Rocha BF, Theodoropoulos TA, Cordeiro JA. Effects of β-blockers on outcome of patients with Chagas’ cardiomyopathy with chronic heart failure. Int. J. Cardiol. 151(2), 205–208 (2011).
   PubMed Web of Science ®Google Scholar
• Theodoropoulos TA, Bestetti RB, Otaviano AP, Cordeiro JA, Rodrigues VC, Silva AC. Predictors of all-cause mortality in chronic Chagas’ heart disease in the current era of heart failure therapy. Int. J. Cardiol. 128(1), 22–29 (2008).
   PubMed Web of Science ®Google Scholar
• Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VC. Predictors of all-cause mortality for patients with chronic Chagas’ heart disease receiving implantable cardioverter defibrillator therapy. J. Cardiovasc. Electrophysiol. 18(12), 1236–1240 (2007).
   PubMed Web of Science ®Google Scholar
• Espinosa RA, Pericchi LR, Carrasco HA, Escalante A, Martínez O, González R. Prognostic indicators of chronic Chagasic cardiopathy. Int. J. Cardiol. 30(2), 195–202 (1991).
   PubMed Web of Science ®Google Scholar
• Topilski I, Rogowski O, Rosso R et al. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J. Am. Coll. Cardiol. 49(3), 320–328 (2007).
   PubMed Web of Science ®Google Scholar
• Shimizu M, Ino H, Okeie K et al. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin. Cardiol. 25(7), 335–339 (2002).
   PubMed Web of Science ®Google Scholar
• Haarmark C, Hansen PR, Vedel-Larsen E et al. The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J. Electrocardiol. 42(6), 555–560 (2009).
   PubMed Web of Science ®Google Scholar
• Panikkath R, Reinier K, Uy-Evanado A et al. Prolonged Tpeak-to-Tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ. Arrhythm. Electrophysiol. 4(4), 441–447 (2011).
   PubMed Web of Science ®Google Scholar
• Ribeiro AL, Cavalvanti PS, Lombardi F, Nunes Mdo C, Barros MV, Rocha MO. Prognostic value of signal-averaged electrocardiogram in Chagas disease. J. Cardiovasc. Electrophysiol. 19(5), 502–509 (2008).
   PubMed Web of Science ®Google Scholar
• Sarabanda AV, Marin-Neto JA. Predictors of mortality in patients with Chagas’ cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter–defibrillators. Pacing Clin. Electrophysiol. 34(1), 54–62 (2011).
   PubMed Web of Science ®Google Scholar
• Ribeiro AL, Rocha MO, Terranova P, Cesarano M, Nunes MD, Lombardi F. T-wave amplitude variability and the risk of death in chagas disease. J. Cardiovasc. Electrophysiol. 22(7), 799–805 (2011).
   PubMed Web of Science ®Google Scholar
• Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathy. Circulation 90(6), 3098–3102 (1994).
   PubMed Web of Science ®Google Scholar
• de Paola AA, Gomes JA, Terzian AB, Miyamoto MH, Martinez Fo EE. Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic Chagasic cardiomyopathy and ventricular arrhythmias. Br. Heart J. 74(3), 293–295 (1995).
   PubMedGoogle Scholar
• Pedrosa RC, Salles JH, Magnanini MM, Bezerra DC, Bloch KV. Prognostic value of exercise-induced ventricular arrhythmia in Chagas’ heart disease. Pacing Clin. Electrophysiol. 34(11), 1492–1497 (2011).
   PubMed Web of Science ®Google Scholar
• Moreira Mda C, Wang Y, Heringer-Walther S, Wessel N, Walther T. Prognostic value of natriuretic peptides in Chagas’ disease: a head-to-head comparison of the 3 natriuretic peptides. Congest. Heart Fail. 15(2), 75–81 (2009).
   PubMedGoogle Scholar
• Barbosa MM, Nunes Mdo C, Ribeiro AL, Barral MM, Rocha MO. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle. Eur. J. Echocardiogr. 8(3), 204–212 (2007).
   PubMed Web of Science ®Google Scholar
• Lima-Costa MF, Cesar CC, Peixoto SV, Ribeiro AL. Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambui Cohort Study of Aging. Am. J. Epidemiol. 172(2), 190–196 (2010).
   PubMed Web of Science ®Google Scholar
• Saravia SG, Haberland A, Bartel S et al. Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas disease. Arch. Pathol. Lab. Med. 135(2), 243–248 (2011).
   PubMed Web of Science ®Google Scholar
• Martinelli PM, da Costa Rocha MO, Teixeira AL, do Carmo Pereira Nunes M, da Silva Camargos ER. Brain-derived neurotrophic factor is up regulated in chronic Chagas disease. Int. J. Cardiol. 149(2), 277–278 (2011).
   PubMed Web of Science ®Google Scholar
• Cunha-Neto E, Nogueira LG, Teixeira PC et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 252–258 (2009).
   PubMed Web of Science ®Google Scholar
• Sternick EB, Martinelli M, Sampaio R et al. Sudden cardiac death in patients with chagas heart disease and preserved left ventricular function. J. Cardiovasc. Electrophysiol. 17(1), 113–116 (2006).
   PubMed Web of Science ®Google Scholar
• Nunes Mdo C, Barbosa Mde M, Brum VA, Rocha MO. Morphofunctional characteristics of the right ventricle in Chagas’ dilated cardiomyopathy. Int J Cardiol. 94, 79–85 (2004).
   PubMed Web of Science ®Google Scholar
• Nunes Mdo C, Rocha MO, Ribeiro AL et al. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas’ cardiomyopathy. Int. J. Cardiol. 127(3), 372–379 (2008).
   PubMed Web of Science ®Google Scholar
• Nunes MC, Barbosa MM, Ribeiro AL, Colosimo EA, Rocha MO. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J. Am. Soc. Echocardiogr. 22(1), 82–88 (2009).
   PubMed Web of Science ®Google Scholar
• Bestetti RB, Dalbo CM, Arruda CA, Correia Filho D, Freitas OC. Predictors of sudden cardiac death for patients with Chagas’ disease: a hospital-derived cohort study. Cardiology 87(6), 481–487 (1996).
   PubMed Web of Science ®Google Scholar
• Nunes MP, Colosimo EA, Reis RC et al. Different prognostic impact of the tissue Doppler-derived E/e’ ratio on mortality in Chagas cardiomyopathy patients with heart failure. J. Heart Lung Transplant. 31(6), 634–641 (2012).
   PubMed Web of Science ®Google Scholar
• Rochitte CE, Oliveira PF, Andrade JM et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J. Am. Coll. Cardiol. 46(8), 1553–1558 (2005).
   PubMed Web of Science ®Google Scholar
• Marin-Neto JA, Marzullo P, Marcassa C et al. Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am. J. Cardiol. 69(8), 780–784 (1992).
   PubMed Web of Science ®Google Scholar
• Simões MV, Pintya AO, Bromberg-Marin G et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am. J. Cardiol. 86(9), 975–981 (2000).
   PubMed Web of Science ®Google Scholar
• Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simões MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC. Cardiovasc. Imaging 2(2), 164–172 (2009).
   PubMed Web of Science ®Google Scholar
• Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simões MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J. Nucl. Med. 52(4), 504–510 (2011).
   PubMed Web of Science ®Google Scholar
• Rassi Jr A, Rassi A, Marin-Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 152–158 (2009).
   PubMed Web of Science ®Google Scholar
• Nunes MC, Reis RC, Colosimo EA et al. Risk estimation approach in Chagas disease is still needed. Int. J. Cardiol. 147(2), 294–296 (2011).
   PubMed Web of Science ®Google Scholar
• Viotti R, Vigliano C, Lococo B et al. [Clinical predictors of chronic Chagasic myocarditis progression]. Rev. Esp. Cardiol. 58(9), 1037–1044 (2005).
   PubMed Web of Science ®Google Scholar
• Rocha MO, Ribeiro AL. A risk score for predicting death in Chagas’ heart disease. N. Engl. J. Med. 355(23), 2488–2489; author reply 2490 (2006).
   PubMed Web of Science ®Google Scholar
• Bestetti RB, Cardinalli-Neto A. Sudden cardiac death in Chagas’ heart disease in the contemporary era. Int. J. Cardiol. 131(1), 9–17 (2008).
   PubMed Web of Science ®Google Scholar
• Benchimol-Barbosa PR. Nonlinear mathematical model for predicting long-term cardiac remodeling in Chagas’ heart disease: introducing the concepts of ‘limiting cardiac function’ and ‘cardiac function deterioration period’. Int. J. Cardiol. 145(2), 219–221 (2010).
   PubMed Web of Science ®Google Scholar
• Pereira Nunes Mdo C, Barbosa MM, Ribeiro AL, Amorim Fenelon LM, Rocha MO. Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor. Rev. Esp. Cardiol. 63(7), 788–797 (2010).
   PubMed Web of Science ®Google Scholar
• Ritt LE, Carvalho AC, Feitosa GS et al. Heart failure survival score in patients with Chagas disease: correlation with functional variables. Rev. Esp. Cardiol. 65(6), 538–543 (2012).
   PubMed Web of Science ®Google Scholar
• Benchimol-Barbosa PR. Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas’ disease. Braz. J. Med. Biol. Res. 40(2), 167–178 (2007).
   PubMed Web of Science ®Google Scholar